BioNTech, based in Mainz, Germany, announced positive results Monday about the Covid-19 vaccine it is developing with Pfizer. Click here to read more.
U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. “It is a great day for science,” Pfizer CEO Albert Bourla told CNBC’s “Squawk Box” Monday morning. [...]
As of 8:00 a.m. ET Thursday, the unofficial U.S. tally stood at 9,488,875 cases and 233,734 deaths -- up by 103,369 (another new record) and 1,096, respectively, in the past 24 hours. Click here to read more.
Deliberately injecting volunteers with COVID to test vaccines ‘faster than large-scale trials’: Bioethics professor
New York University bioethics professor Dr. Arthur Caplan says human challenge studies whereby researchers inject volunteers with COVID-19 and then test the efficiency of vaccines, yields faster and more reliable data than large, traditional vaccine testing processes because they are controlling the environment. Click here to watch the video.
Arthur L. Caplan, PhD Director, Division of Medical Ethics, New York University Langone Medical Center, New York, NY discusses the known COVID-19 vaccine manufacturing and distribution considerations and the unknown timeline for public access. Click here to watch the video.
October was a good month for Gilead Sciences, the giant manufacturer of antivirals headquartered in Foster City, California. On 8 October, the company inked an agreement to supply the European Union with its drug remdesivir as a treatment for COVID-19—a deal potentially worth more than $1 billion. Two weeks later, on 22 October, the U.S. [...]